Nuvalent
VerifiedWork at Nuvalent.
Nuvalent, Inc. is a clinical-stage biotechnology company developing selective small-molecule medicines for cancer. Its pipeline includes targeted therapies for ROS1-positive, ALK-positive, and HER2-altered non-small cell lung cancer, including zidesamtinib (NVL-520), neladalkib (NVL-655), and NVL-330.
Healthcare Biotechnology
Open roles at Nuvalent
1 open rolesSubscribe to Career Resources.
Get the latest career advice, industry insights, and job opportunities delivered straight to your inbox.
